Quantifying Nanomolar Protein Concentrations Using Designed DNA Carriers and Solid-State Nanopores by Kong, Jinglin et al.
Quantifying Nanomolar Protein Concentrations Using Designed DNA
Carriers and Solid-State Nanopores
Jinglin Kong, Nicholas A. W. Bell, and Ulrich F. Keyser*
Cavendish Laboratory, University of Cambridge, JJ Thomson Ave, Cambridge, CB3 0HE, United Kingdom
*S Supporting Information
ABSTRACT: Designed “DNA carriers” have been proposed as a new
method for nanopore based speciﬁc protein detection. In this system, target
protein molecules bind to a long DNA strand at a deﬁned position creating
a second level transient current drop against the background DNA
translocation. Here, we demonstrate the ability of this system to quantify
protein concentrations in the nanomolar range. After incubation with target
protein at diﬀerent concentrations, the fraction of DNA translocations
showing a secondary current spike allows for the quantiﬁcation of the
corresponding protein concentration. For our proof-of-principle experi-
ments we use two standard binding systems, biotin−streptavidin and
digoxigenin−antidigoxigenin, that allow for measurements of the concentration down to the low nanomolar range. The results
demonstrate the potential for a novel quantitative and speciﬁc protein detection scheme using the DNA carrier method.
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Proteins are essential for living systems and serve in diverseroles for instance in transport, catalysis, molecular motion
and structural support. Most of their functions are modulated
and controlled by both the identity and abundance. The
accurate and speciﬁc measurement of protein concentrations is
therefore of fundamental importance in biological and medical
research, drug screening, and disease diagnosis. Several well-
established methods are used for determining protein
concentration. High accuracy can be achieved using radio
labeling1 and mass spectrometry2 in which protein molecules
are analyzed at peptide or single amino acid level. Speciﬁc
binding based methods such as electrophoretic mobility shift
(EMSA),3 ﬂuorescent polarization (FP),4 and enzyme-linked
immunosorbent assays (ELISA)5 are commonly used for
routine protein concentration determination. Eﬀorts have
been made toward lowering the detection limit, required
sample volumes and throughput by introducing micro or nano
arrays6 and nanoparticles.7
Solid-state nanopore based sensing is being actively
investigated as a versatile platform for single-molecule protein
sensing. This research is driven by the potential for fast
detection, avoiding the sometimes cumbersome ﬂuorescent
labeling of proteins, with a single molecule sensing method
which can be integrated into silicon electronics. Furthermore,
since the throughput of the acquired signal is independent of
the sample volume, and rather depends on the concentration,
there is the possibility for microﬂuidic integration8 which
provides an advantage over established techniques such as
ELISA and radio-labeling. However, results to-date using solid-
state nanopore indicate that the translocation speeds of most
protein monomers are too fast for all translocations to be
accurately recorded at typical experimental bandwidths.9
Although high bandwidth systems combined with thin
membranes can record most translocations in a limited voltage
range, the fast translocation aspect makes it particularly
challenging to accurately determine protein concentration.10
Another complication is added by the potential for various
protein-nanopore wall interactions11 limiting the ability to
diﬀerentiate protein species. Creating a binding site for a target
protein on a long DNA strand (DNA carrier) and measuring
the translocation signals of the complex helps to address these
problems in protein monomer only translocations.12 First the
binding site can be selective for a certain protein which enables
its identiﬁcation. Second the easily discernible signal from the
current event produced by the DNA strand provides a marker
for predicting when the protein signal will occur. Therefore,
protein signals are only analyzed when occurring during the
DNA signals rather than the whole experimental current trace.
In this study we employ the method of DNA carriers for
evaluating protein concentration (Figure 1). We determine the
concentration by measuring the fraction of DNA carriers which
show a secondary signal indicating the presence of a protein.
Two model systems are investigated, namely, biotin−
streptavidin and digoxigenin−antidigoxigenin. Binding curves
are constructed by varying the protein concentration in these
two systems. Our results show good agreement between the
nanopore based binding curve and a model using a dissociation
constant value determined by other standard assays. For the
biotin−streptavidin system, we measure a small deviation from
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the expected binding curve which we assign to the lower signal-
to-noise ratio for the 52.8 kDa streptavidin bound on the DNA.
The basic structure of the DNA carrier is fabricated by using
a linearized 7.2 kb m13mp18 virus genome (New England
BioLabs) and 190 designed oligonucleotides (Integrated DNA
Technologies) each 38 bases in length. These oligonucleotides
hybridize to the m13mp18 single-stranded (ss) DNA forming a
long double-strand. The oligonucleotide in the center of the
DNA carrier was modiﬁed with a 5′ extension of three
thymines and either digoxigenin or biotin. Full details of the
assembly were described previously.12
We use glass nanopores derived from the laser-assisted
pulling of quartz glass capillaries with outer diameters of 0.5
mm and inner diameter of 0.2 mm (Sutter Instruments, USA).
In order to optimize the signal-to-noise ratio, two slightly
diﬀerent pulling programs were used for the two diﬀerent
protein systems. The detailed parameters for nanopore
fabrication can be found in the Supporting Information
(Table S1). The magnitude of the dsDNA current drops is
−0.160 ± 0.023 nA and −0.146 ± 0.025 nA for pulling
program 1 and 2, respectively (distributions shown in
Supporting Information, Figure S1, errors are standard
deviations). Slightly larger nanopores produced by program 2
were used for the digoxigenin system with the aim of reducing
unspeciﬁc protein−nanopore surface interactions. The dsDNA
current level was used in the data analysis protocol for setting
the appropriate threshold (see Supporting Information, Figure
S2).
Monovalent streptavidin was generously provided by the
Howarth Lab.13 The three digoxigenin antibody samples were
purchased from three companies (Roche, Invitrogen, and
Abcam) (monoclonal, isotype IgG). The protein concen-
trations were checked by measuring absorbance at 280 nm
(Nanodrop 2000) before any dilutions were done. DNA
carriers with 3 nM concentration were incubated with the target
proteins for 30 min in 100 mM NaCl and 2 mM MgCl2
buﬀered with 10 mM Tris-HCl (pH ∼ 8). The sample was then
diluted by adding the same volume of 8 M LiCl, 100 mM NaCl,
and 2 mM MgCl2 with the same buﬀer condition, making the
ﬁnal DNA carrier concentration of 1.5 nM in 4 M LiCl, 100
mM NaCl, and 2 mM MgCl2 buﬀered with 10 mM Tris-HCl
(pH ∼ 7.5). The protein concentrations used range from 0 to
5.6 nM for streptavidin and 0 to 31 nM for the digoxigenin
antibody. All translocation measurements were carried out at
600 mV applied voltage. The ionic current data was acquired
using an Axopatch 200B with a sampling frequency of 250 kHz
and ﬁltered at 49.9 kHz with an external 8-pole Bessel ﬁlter.
For the independent determination of dissociation constants
(Kd), electrophoretic mobility shift assay (EMSA) and
ﬂuorescence polarization (FP) were used to investigate the
aﬃnity of these two standard pairs. Detailed information on
these assays is given in the Supporting Information.
The raw ionic current data contain translocations from free
protein, folded DNA carriers (observed in wide diameter
nanopores as those used here), and unfolded DNA carriers
which pass through in a head-to-tail fashion. There are also
fragments of the full DNA carrier length due to the synthesis
procedure. It is important to note that we ﬁlter the
translocations to remove all subpopulations except the full
length, unfolded DNA carriers. This is achieved by an ECD
(Event Charge Deﬁcit) threshold and ionic current threshold
(1.5 times current drop amplitude corresponding to double-
stranded DNA) at the beginning and end of the events. Details
of this process were described previously.12
An example translocation event after these ﬁltering steps is
shown in Figure 1b. A searching window of 25% of the event
duration is created in the middle of each translocation to test
for the presence of a secondary peak due to the bound protein.
The threshold to ﬁnd the peak was deﬁned with a factor (I/
IDNA) based on the dsDNA current amplitude. The fraction of
occupied events decreases with the increasing threshold factor
(Supporting Information, Figure S2). We chose to use a
threshold of 1.4 times the magnitude over the DNA carrier
signal, IDNA, for all the data analysis in this work. This empirical
threshold provides a clear diﬀerentiation between the protein
binding peak and the false positive peak observed in DNA
carrier measurements where there is no protein present.
We chose the biotin−streptavidin interaction as it is one of
the strongest known noncovalent interactions with a
dissociation constant of Kd ∼ 10−15 M. Due to its extremely
high aﬃnity, this interaction is an ideal model system for
determining the ability of measuring protein concentrations in
the nanomolar range. First, we incubated an approximately four
times stoichiometric excess of monovalent streptavidin with the
DNA carrier. A few typical example events of the occupied
biotin DNA carrier are shown in Figure 2a. An extra transient
current drop, representing a protein binding, can be found in
each of the example traces and is positioned in the middle of
the observation window of each event. A histogram of the peak
Figure 1. (a) Schematic representation of incubated DNA carrier
(black line) and protein complexes (black line with a blue cuboid
attached) translocating through a nanopore driven by the electric ﬁeld.
(b) Example occupied carrier translocation event shows an extra
second level current drop in the very middle of the event, which is
caused by the targeted protein binding. To ﬁnd the positive events
through data processing, we set a searching window of 25% of the total
event duration. (c, d, e) Schematic and example DNA carrier
translocation events after incubation with targeted protein of diﬀerent
concentrations. The concentration ratios (cProtein/cCarrier) are decreasing
from c to e. The carriers are fully occupied in c showing that all the
carrier translocation events have secondary current spike positioned in
the middle (occupied events), while in d and e, less occupied events
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current drop (red) and an all points histogram (blue) of all
linear translocation events are shown in Figure 2b. The two
peaks in the histograms are overlapping indicating that the level
of current drop caused by the monovalent streptavidin is
relatively close to that of the dsDNA level. This explains why
some streptavidin translocations may go undetected due to the
required threshold for event detection. Biotin−streptavidin is
known to retain its high aﬃnity in a wide range of conditions
and extremes of pH, temperature and detergents14 are needed
to break the interaction. Therefore, we can safely assume that
the aﬃnity remains signiﬁcantly high, below subnanomolar
even in the high salt solution used for nanopore experiments.
Thus, we expect to observe a linear increase in the occupied
fraction of DNA carriers as a function of the streptavidin
concentration until all DNA carriers are saturated. As a control,
EMSA was used to measure the fraction of biotinylated DNA
bound as a function of streptavidin concentration. A 38 bp
DNA duplex was synthesized with a three thymine and biotin
label and the protein was titrated against this duplex. The upper
bands in the gel image (Figure 2c) correspond to the duplexes
with bound streptavidin while the lower bands are the unbound
duplexes. The binding fraction obtained from the gel band
intensity is plotted in Figure 2c. A good agreement is found
between the expected linear increase (gray dashed line) and the
gel intensity data.
Figure 2d depicts the fraction of occupied events as a
function of the concentration ratio (cStreptavidin/cCarrier) for the
nanopore experiments. The lower limit is ∼0.1 which is due to
the false positive rate of protein-like signals observed on bare
DNA. This false positive can be caused by the presence of folds
or knots in the DNA or other factors. As expected, a linear
increase of occupied fraction is observed until the curve levels
oﬀ at a fraction of 0.8. This leveling oﬀ at 0.8 instead of 1 is due
to the signal-to-noise ratio of the streptavidin system. Some
protein events are buried in the noise−as suggested by Figure
2b. The peak current histogram for streptavidin detection
(Figure 2b, top) overlaps the current distribution of the dsDNA
level (Figure 2b, bottom). Additionally, the occupied fraction
saturated at a concentration ratio of 2 rather than 1. The
continuing increase beyond the expected ratio of 1 is likely due
to nonspeciﬁc adsorption to walls of the ﬂuidic chip. This is a
known problem in microﬂuidic chips which is particularly
prevalent at the nanomolar concentrations used here.15 We
note that each point in Figure 2d shows an average of 6−25
independent nanopore measurements and 2 or 3 diﬀerent
protein sample dilution runs. We measure signiﬁcant variations
in the occupied fraction during these repeats which are
explained by signal size variations from diﬀerent nanopores
and the variability in nonspeciﬁc adsorption during the protein
handling at nanomolar concentration (Supporting Information,
Table S3).
In a second demonstration of this method, we investigated
how the occupied carrier fraction varies with a digoxigenin−
antidigoxigenin (Anti-dig) system. The molecular weight of
antidigoxigenin is 150 kDasigniﬁcantly bigger than strepta-
vidin at 52.8 kDa. Indeed, the peak current amplitude of the
occupied carrier is typically bigger than streptavidin (Figure 3a)
which improves the signal-to-noise ratio and thus our detection
accuracy. The improved resolution can also be directly
observed in Figure 3b, in which the overlap between dsDNA
level and protein binding level is almost nonexistent compared
to the data in Figure 2b.
The dissociation constant for antidigoxigenin is in the range
of nM at physiological salt concentrations.16 Here, we
measured the dissociation constant of the monoclonal
antidigoxigenin by ﬂuorescence polarization. A Kd of ∼3.5
nM was estimated in buﬀers with and without 4 M LiCl which
is used in the nanopore experiments (see Supplementary Figure
S4). Details of the ﬁtting model are described in Supporting
Information S4.
As shown in Figure 3c, the upper limit of the occupied carrier
fraction is ∼0.95 which is considerably higher than that of the
biotin−streptavidin system (∼0.8). This clear improvement is
due to the higher signal-to-noise ratio of this larger antibody
system and conﬁrms our assertion that some streptavidin−
biotin carrier translocations have a current value for the
streptavidin level which is not high enough above the noise for
detection. The small remaining fraction which does not show a
positive signal for antidigoxigenin is due to a small fraction of
Figure 2. Concentration measurement of streptavidin using DNA
carriers. (a) Schematic representation of biotin−streptavidin systems
and examples of occupied DNA carrier translocation events. The
monovalent streptavidin (blue cuboid) is 52.8 kDa. (b) Histogram of
the peak current drop (red) and an all points histogram (blue) of all
linear translocation events. The histograms are ﬁtted by a Gaussian
function, where the main peak in the all point histogram (μB)
determines the dsDNA level and the center of the peak current drop
(μO) shows the protein binding signal. The concentration ratio was 3.8
(cStreptavidin/cCarrier), cStreptavidin = 5.8 nM. (c) EMSA showing titration of
monovalent streptavidin against a biotin labeled DNA duplex of 38 bp.
The corresponding gel image is shown in the inset. The intensity of
the lanes is determined using ImageJ. Lane L is a DNA ladder
reference (low molecular weight from 25 bp to 766 bp). The
concentration of the DNA duplex was 80 nM for each lane. Lanes 1−7
correspond to biotin labeled oligo incubated with streptavidin of
diﬀerent concentration ratio (cStreptavidin/cOligo) of 0, 0.1, 0.2, 0.5, 1, 1.5,
and 2, respectively. The gray dashed line shows the linear increase
expected for an inﬁnitely high aﬃnity pairing at equilibrium. (d)
Binding curve based on nanopore measurements. A DNA carrier of 1.5
nM concentration was incubated with monovalent protein from 0 nM
to 5.6 nM. Error bars are standard error of the mean from diﬀerent
nanopores. The binding curve is obtained from a total of n = 70
nanopore experiments. The event numbers in the plots are 434, 479,
2044, 689, 174, and 905 for data points at the concentration ratio from
0 to 3.8, respectively (statistics in Supporting Information S7).
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imperfect DNA carriers whereby not all contain the digoxigenin
labeled oligonucleotide.
It has to be noted that inﬂuencing factors mentioned
previously with the biotin system also apply here. Protein
concentration variations among diﬀerent dilutions can occur
due to losses caused by nonspeciﬁc surface binding. Also, in
particular for antibodies, our speciﬁc protein detection method
is sensitive for the active antibodies in the sample which can
therefore be diﬀerent from the concentrations determined
spectrophotometrically.
In order to highlight the fact that we can assess active
antibody concentrations, we decided to compare binding curves
of three antidigoxigenin protein samples (A, B, and C) from
diﬀerent suppliers. All of the nanopore measurements were
done with the same protocol described previously. As shown in
Figure 4a, the three binding curves reveal clear diﬀerences: the
saturation point of sample A is at the concentration ratio of ∼4,
while the occupied fraction saturated at the ratio of ∼2 for
sample B and C. If the dissociation constant is assumed to be
the same for all samples, the active protein concentration can
be determined. Figure 4b shows the increase in the zoomed in
range before the saturated concentration ratio. Accordingly,
sample B and C contain approximately twice more active
antibodies which is consistent with the EMSA results in Figure
4c. EMSA gel images are in the Supporting Information, Figure
S3.
The dynamic range for the high aﬃnity binding protein
systems tested here is approximately 1 order of magnitude. This
lower limit is determined by the 5−10% of translocations that
have false positive protein signal and the upper limit is the level
at which the DNA is saturated with protein. The particular
window of protein concentration tested can then be adjusted by
changing the DNA carrier concentration (which we kept at 1.5
nM in these experiments). Since the translocation frequency of
our DNA carriers is independent of the incubated protein
concentration (Figure S6), higher concentrations could be used
to achieve better statistics. To extend the dynamic range, a
reduction in false positives by using shorter DNA lengths which
show less folding is promising17 or by strategies to increase the
bending rigidity of the DNA and therefore decrease the
frequency of folds. Protein systems with lower binding aﬃnities
could also be investigated by employing chemical cross-linking
strategies. All the latter techniques should greatly enhance the
application range to other relevant protein systems. It is also
important to note here that the single molecule nanopore
approach lends itself to the possibility of multiplexed sensing
Figure 3. Concentration measurement of antidigoxigenin using DNA
carriers. (a) Schematic representation of digoxigenin−antidigoxigenin
system and examples of occupied digoxigenin carrier translocation
events. The digoxigenin antibody (green Y-shaped structure) is about
150 kDa. (b) Histogram of the peak current drop (red) together with
an all points histogram (blue) of all linear translocation events. The
histograms are ﬁtted by a Gaussians function. The concentration ratio
was 10.5 (cAnti-dig/cCarrier), cAnti-dig = 15.8 nM. (c) Binding curve based
on nanopore measurements. A DNA carrier concentration of 1.5 nM
was incubated with monovalent protein from 0 nM to 31 nM. Error
bars are standard errors of the mean (not included for data points with
two nanopores at the concentration ratio of 10.5 and 20.9). The plot
represents data are from n = 25 nanopores. The event numbers in the
plots are 94, 141, 159, 145, 111, 93, and 32 for data points at the
concentration ratio from 0 to 21 respectively (statistics in Supporting
Information S7).
Figure 4. Comparison of active Anti-dig concentrations using three
antibody samples (A, B, and C). (a) Binding curves obtained from
three antidigoxigenin samples. The curve of sample A is the same as in
Figure 3c. The event numbers considered for sample B are 179, 218,
60, 116, 341, and 507 for data points at the concentration ratio from
0.25 to 8, respectively. The event numbers considered for sample C
are 182, 253, 279, 683, 269, and 301 for data points at the same
concentration ratio from 0.25 to 8, respectively (statistics in
Supporting Information S8). (b) Zoomed-in concentration depend-
ence of the occupied carrier fraction below the saturation point.
Dashed lines are added as a guide to the eye. (c) Concentration
dependence of the binding fraction obtained from EMSA.
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which allows us to measure multiple proteins with a single
nanopore.18
In this work, we have shown that a combination of solid-state
nanopores and designed DNA carriers can be used as a method
for measuring nanomolar level of protein concentration. Several
other studies of the translocation of DNA−protein complexes
through solid-state nanopores have been used to qualitatively
assess the presence of binding between DNA and proteins
including the DNA-repair protein RecA,19 DNA antibodies20
and transcription factors.21 Other interesting work with similar
ideas has been used to detect PNA and DNA targets where
eﬀorts have been made toward quantiﬁcation.22 The results
here show that quantitative estimates of protein concentration
can be made using our DNA carrier analysis system by
measuring the concentration dependence of the occupied
carrier fraction. The working protein concentrations are at
nanomolar range, and we use microﬂuidic chips with ∼10 μL
volume so the total amount of protein needed is only 10 fmol.
The technique gives selectivity via protein binding sites and can
be used for proteins in their native conformations without the
requirement for any chemical modiﬁcations.
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(11) Li, W.; Bell, N. A.; Hernańdez-Ainsa, S.; Thacker, V. V.;
Thackray, A. M.; Bujdoso, R.; Keyser, U. F. Single protein molecule
detection by glass nanopores. ACS Nano 2013, 7 (5), 4129−4134.
(12) Bell, N. A.; Keyser, U. F. Specific protein detection using
designed DNA carriers and nanopores. J. Am. Chem. Soc. 2015, 137
(5), 2035−2041.
(13) Howarth, M.; Chinnapen, D. J.; Gerrow, K.; Dorrestein, P. C.;
Grandy, M. R.; Kelleher, N. L.; El-Husseini, A.; Ting, A. Y. A
monovalent streptavidin with a single femtomolar biotin binding site.
Nat. Methods 2006, 3 (4), 267−273.
(14) Rybak, J.-N.; Scheurer, S. B.; Neri, D.; Elia, G. Technical Brief
Purification of biotinylated proteins on streptavidin resin: A protocol
for quantitative elution. Proteomics 2004, 4, 2296−2299.
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